PharmaCyte Biotech (PMCB) Earnings Date, Estimates & Call Transcripts → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free PMCB Stock Alerts $2.11 -0.01 (-0.47%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJul. 29EstimatedActual EPS (Mar. 18) -$0.65 Missed By -$0.65 Get PharmaCyte Biotech Earnings AlertsEnter your email address below to receive the latest news and earnings results for PMCB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePMCB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PMCB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details PMCB Earnings Date and InformationPharmaCyte Biotech last posted its earnings data on March 18th, 2024. The reported ($0.65) EPS for the quarter. PharmaCyte Biotech has generated ($1.20) earnings per share over the last year (($1.20) diluted earnings per share). PharmaCyte Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off prior year's report dates.Read More PharmaCyte Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/29/2024Estimated)------- 3/18/2024Q3 2024-($0.65)($0.65)($0.65)--12/15/2023Q2 2024-($0.64)($0.64)($1.02)--9/18/2023Q1 2024-($0.28)($0.28)($0.28)--7/31/2023Q4 2023-($0.01)($0.01)($0.01)--3/16/2023Q3 2023-($0.04)($0.04)($0.04)--12/14/2022Q2 2023-($0.09)($0.09)($0.09)-- Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 9/14/2022Q1 2023($0.07)($0.07)-($0.07)--7/28/2022Q4 2022-($0.06)($0.06)($0.06)--3/15/2022Q3 2022($0.05)($0.04)+$0.01($0.04)--12/15/2021Q2($0.07)($0.06)+$0.01($0.06)--9/14/2021Q1 2022-($0.64)($0.64)($0.64)-- PharmaCyte Biotech Earnings - Frequently Asked Questions When is PharmaCyte Biotech's earnings date? PharmaCyte Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off last year's report dates. Learn more on PMCB's earnings history. How much profit does PharmaCyte Biotech generate each year? PharmaCyte Biotech (NASDAQ:PMCB) has a recorded net income of -$4.32 million. PMCB has generated -$1.20 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Aptose Biosciences Earnings Results AIM ImmunoTech Earnings Results NanoString Technologies Earnings Results Evaxion Biotech A/S Earnings Results Senti Biosciences Earnings Results ZIVO Bioscience Earnings Results Coeptis Therapeutics Earnings Results Inhibikase Therapeutics Earnings Results BioCardia Earnings Results Pluri Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:PMCB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCyte Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
